Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases: Evaluation of Therapeutics for MERS-CoV

NIH RePORTER · NIH · N01 · $3,485 · view on reporter.nih.gov ↗

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

Key facts

NIH application ID: 10329654
Project number: 272201500005I-P00007-27200003-1
Recipient: DYNPORT VACCINE COMPANY, LLC
Principal Investigator: DAVID SHUMWAY
Activity code: N01
Funding institute: NIH
Fiscal year: 2021
Award amount: $3,485
Award type: —
Project period: 2016-08-23 → 2019-12-31